High-throughput transcriptomic analysis nominates proteasomal genes as age-specific biomarkers and therapeutic targets in prostate cancer

S. G. Zhao, W. C. Jackson, V. Kothari, M. J. Schipper, N. Erho, J. R. Evans, C. Speers, D. A. Hamstra, Y. S. Niknafs, P. L. Nguyen, E. M. Schaeffer, A. E. Ross, R. B. Den, E. A. Klein, Robert Brian Jenkins, E. Davicioni, F. Y. Feng

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Although prostate cancer (PCa) is hypothesized to differ in nature between younger versus older patients, the underlying molecular distinctions are poorly understood. We hypothesized that high-throughput transcriptomic analysis would elucidate biological differences in PCas arising in younger versus older men, and would nominate potential age-specific biomarkers and therapeutic targets.Methods:The high-density Affymetrix GeneChip platform, encompassing >1 million genomic loci, was utilized to assess gene expression in 1090 radical prostatectomy samples from patients with long-term follow-up. We identified genes associated with metastatic progression by 10 years post-treatment in younger (age

Original languageEnglish (US)
Pages (from-to)229-236
Number of pages8
JournalProstate Cancer and Prostatic Diseases
Volume18
Issue number3
DOIs
StatePublished - Sep 14 2015

Fingerprint

Prostatic Neoplasms
Biomarkers
Prostatectomy
Genes
Gene Expression
Therapeutics

ASJC Scopus subject areas

  • Oncology
  • Urology
  • Cancer Research

Cite this

High-throughput transcriptomic analysis nominates proteasomal genes as age-specific biomarkers and therapeutic targets in prostate cancer. / Zhao, S. G.; Jackson, W. C.; Kothari, V.; Schipper, M. J.; Erho, N.; Evans, J. R.; Speers, C.; Hamstra, D. A.; Niknafs, Y. S.; Nguyen, P. L.; Schaeffer, E. M.; Ross, A. E.; Den, R. B.; Klein, E. A.; Jenkins, Robert Brian; Davicioni, E.; Feng, F. Y.

In: Prostate Cancer and Prostatic Diseases, Vol. 18, No. 3, 14.09.2015, p. 229-236.

Research output: Contribution to journalArticle

Zhao, SG, Jackson, WC, Kothari, V, Schipper, MJ, Erho, N, Evans, JR, Speers, C, Hamstra, DA, Niknafs, YS, Nguyen, PL, Schaeffer, EM, Ross, AE, Den, RB, Klein, EA, Jenkins, RB, Davicioni, E & Feng, FY 2015, 'High-throughput transcriptomic analysis nominates proteasomal genes as age-specific biomarkers and therapeutic targets in prostate cancer', Prostate Cancer and Prostatic Diseases, vol. 18, no. 3, pp. 229-236. https://doi.org/10.1038/pcan.2015.22
Zhao, S. G. ; Jackson, W. C. ; Kothari, V. ; Schipper, M. J. ; Erho, N. ; Evans, J. R. ; Speers, C. ; Hamstra, D. A. ; Niknafs, Y. S. ; Nguyen, P. L. ; Schaeffer, E. M. ; Ross, A. E. ; Den, R. B. ; Klein, E. A. ; Jenkins, Robert Brian ; Davicioni, E. ; Feng, F. Y. / High-throughput transcriptomic analysis nominates proteasomal genes as age-specific biomarkers and therapeutic targets in prostate cancer. In: Prostate Cancer and Prostatic Diseases. 2015 ; Vol. 18, No. 3. pp. 229-236.
@article{b936972e38a24842b9e88bde03f60417,
title = "High-throughput transcriptomic analysis nominates proteasomal genes as age-specific biomarkers and therapeutic targets in prostate cancer",
abstract = "Although prostate cancer (PCa) is hypothesized to differ in nature between younger versus older patients, the underlying molecular distinctions are poorly understood. We hypothesized that high-throughput transcriptomic analysis would elucidate biological differences in PCas arising in younger versus older men, and would nominate potential age-specific biomarkers and therapeutic targets.Methods:The high-density Affymetrix GeneChip platform, encompassing >1 million genomic loci, was utilized to assess gene expression in 1090 radical prostatectomy samples from patients with long-term follow-up. We identified genes associated with metastatic progression by 10 years post-treatment in younger (age",
author = "Zhao, {S. G.} and Jackson, {W. C.} and V. Kothari and Schipper, {M. J.} and N. Erho and Evans, {J. R.} and C. Speers and Hamstra, {D. A.} and Niknafs, {Y. S.} and Nguyen, {P. L.} and Schaeffer, {E. M.} and Ross, {A. E.} and Den, {R. B.} and Klein, {E. A.} and Jenkins, {Robert Brian} and E. Davicioni and Feng, {F. Y.}",
year = "2015",
month = "9",
day = "14",
doi = "10.1038/pcan.2015.22",
language = "English (US)",
volume = "18",
pages = "229--236",
journal = "Prostate Cancer and Prostatic Diseases",
issn = "1365-7852",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - High-throughput transcriptomic analysis nominates proteasomal genes as age-specific biomarkers and therapeutic targets in prostate cancer

AU - Zhao, S. G.

AU - Jackson, W. C.

AU - Kothari, V.

AU - Schipper, M. J.

AU - Erho, N.

AU - Evans, J. R.

AU - Speers, C.

AU - Hamstra, D. A.

AU - Niknafs, Y. S.

AU - Nguyen, P. L.

AU - Schaeffer, E. M.

AU - Ross, A. E.

AU - Den, R. B.

AU - Klein, E. A.

AU - Jenkins, Robert Brian

AU - Davicioni, E.

AU - Feng, F. Y.

PY - 2015/9/14

Y1 - 2015/9/14

N2 - Although prostate cancer (PCa) is hypothesized to differ in nature between younger versus older patients, the underlying molecular distinctions are poorly understood. We hypothesized that high-throughput transcriptomic analysis would elucidate biological differences in PCas arising in younger versus older men, and would nominate potential age-specific biomarkers and therapeutic targets.Methods:The high-density Affymetrix GeneChip platform, encompassing >1 million genomic loci, was utilized to assess gene expression in 1090 radical prostatectomy samples from patients with long-term follow-up. We identified genes associated with metastatic progression by 10 years post-treatment in younger (age

AB - Although prostate cancer (PCa) is hypothesized to differ in nature between younger versus older patients, the underlying molecular distinctions are poorly understood. We hypothesized that high-throughput transcriptomic analysis would elucidate biological differences in PCas arising in younger versus older men, and would nominate potential age-specific biomarkers and therapeutic targets.Methods:The high-density Affymetrix GeneChip platform, encompassing >1 million genomic loci, was utilized to assess gene expression in 1090 radical prostatectomy samples from patients with long-term follow-up. We identified genes associated with metastatic progression by 10 years post-treatment in younger (age

UR - http://www.scopus.com/inward/record.url?scp=84939251543&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939251543&partnerID=8YFLogxK

U2 - 10.1038/pcan.2015.22

DO - 10.1038/pcan.2015.22

M3 - Article

C2 - 25986914

AN - SCOPUS:84939251543

VL - 18

SP - 229

EP - 236

JO - Prostate Cancer and Prostatic Diseases

JF - Prostate Cancer and Prostatic Diseases

SN - 1365-7852

IS - 3

ER -